Advent Health Cancer Institute is a clinical research site located in Orlando, Florida, United States 32804.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Advent Health Cancer Institute has participated in 8 clinical trials with 4 currently active.
Therapeutic areas: Breast Cancer, Advanced Solid Tumor, Metastatic Solid Tumor.
Sponsors: Novartis Pharmaceuticals, BeiGene, Jazz Pharmaceuticals.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Advent Health Cancer Institute has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Advent Health Cancer Institute has 8 clinical trials on record, with 4 currently active. Their work covers Breast Cancer, Advanced Solid Tumor, Metastatic Solid Tumor.
Yes — Advent Health Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.